Mds Podcast

Dr. Sarah Lidstone interviews Dr. Indu Subramanian about her recent paper, "Unmet needs of women with Parkinson's disease: Gaps and Controversies," in Movement Disorders. Read the article.

For the sixth episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Christine Klein to discuss the approach to reviewing a review article.

A recent trial showed no benefit of 1mg rasagiline versus placebo on 1-year progression in an early Parkinson's disease cohort. The investigators used a novel method to track disease progression with MRI, apart from usual clinical standards. Dr. David Vaillancourt shares the results of this trial recently published in the Movement Disorders Journal. Read the article.

For this episode of our special series focused on the peer review process, Dr. Kirby speaks with Dr. Tony Lang about how to approach reviewing an original scientific article.

Dr. Tiago Outeiro interviews Dr. Morgane Linard about the recently published article, "Infectious Agents as Potential Drivers of α-Synucleinopathies." Read the Article.

Dr. Di Luca discusses how to approach and review case reports and case series in movement disorders with Prof. Bhatia.

A discussion with Dr. Thaler on the findings and implications of a study on the background of importance of GBA mutations and GCase activity in Parkinson's disease.

This is the third episode of the special series focused on the peer review process. In this episode, Dr. Kirby speaks with Dr. Jon Stoessl about what journal editors are looking for in a good review. He provides practical tips for writing an effective peer review.

For the second episode of the special series focused on the peer review process, Dr. Prasad speaks with Prof. Deuschl about the crucial first part of the peer review process - identifying reviewers, and understanding when a reviewer should accept or decline an invitation to review.

Prof. Lozano shares the results of the phase 2 clinical trial showing safety and feasibility of the staged bilateral MR-guided focus ultrasound thalamotomy in 10 patients. Read the article.

For the first episode of the special series focused on the peer review process, Dr. Di Luca speaks with Dr. Goetz about the importance and most important aspects of a peer review.

Dr. Hugo Morales discusses "Neuropsychiatric Features of Punding and Hobbyism in Parkinson's Disease," by Dr. Pedro Barbosa et al., from Movement Disorders Clinical Practice."

Dr. Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in Movement Disorders Clinical Practice on a "Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms."

Dr. Hoglinger discusses the article he recently published in the Movement Disorders Journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations.

Dr. Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today.

The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD.

Dr. Matarazzo speaks with Prof. Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression.

Dr. Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders Journal, highlighting the impact on several factors on the variability of movement disorders.

Dr. Schaefer discusses with Dr. Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.

Dr. Schaefer speaks with Dr. Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease.